TY  - JOUR
AU  - Vilorio-Marqués, Laura
AU  - Castañón Fernández, Christelle
AU  - Mora, Elvira
AU  - Gutiérrez, Lorena
AU  - Rey Bua, Beatriz
AU  - Jiménez Lorenzo, Maria José
AU  - Díaz Beya, Marina
AU  - Vara Pampliega, Miriam
AU  - Molero, Antonieta
AU  - Sánchez-García, Joaquín
AU  - Calabuig, Marisa
AU  - Cedena, Maria Teresa
AU  - Chen-Liang, Tzu
AU  - Díaz Santa, Johana Alejandra
AU  - Padilla, Irene
AU  - Hernández, Francisca
AU  - Díez, Rosana
AU  - Asensi, Pedro
AU  - Xicoy, Blanca
AU  - Sanz, Guillermo
AU  - Valcárcel, David
AU  - Diez-Campelo, María
AU  - Bernal, Teresa
PY  - 2022
DO  - 10.1177/20406207221127547
SN  - 2040-6207
UR  - http://hdl.handle.net/10668/20232
T2  - Therapeutic advances in hematology
AB  - The consequences of infectious toxicity of hypomethylating agents (HMAs) on overall survival (OS) of patients diagnosed with high-risk myeloid neoplasms have not been thoroughly investigated. We aimed to evaluate whether infectious events (IEs)...
LA  - en
KW  - acute myeloid leukemia
KW  - hypomethylating agent
KW  - infection
KW  - myelodysplastic syndrome
KW  - treatment outcome
TI  - Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.
TY  - research article
VL  - 13
ER  -